SCHEMBL24317865

SCHEMBL24317865

COCC(C(=O)NC=O)N1C(=O)c2cccc3c(Br)ccc1c23

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP1B1 Q16678 12/20 0.40
ALDH1A1 P00352 4/20 0.38
POLB P06746 2/20 0.38
RXFP1 Q9HBX9 1/20 0.38
KDM4E B2RXH2 4/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KMT2A Q03164 2/20 0.35
MEN1 O00255 1/20 0.35
NPC1 O15118 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
PABPC1 P11940 1/20 0.35
GAA P10253 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
BRD4 O60885 1/20 0.33
BRD1 O95696 1/20 0.33
TAF1 P21675 1/20 0.33
BRPF1 P55201 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24315711 0.73 CYP1B1 (0.40) CYP1B1ALDH1A1POLBRXFP1KDM4E
SCHEMBL24317634 0.71 CYP1B1 (0.41) CYP1B1ALDH1A1POLBRXFP1KDM4E
SCHEMBL29531869 0.71 CYP1B1 (0.41) CYP1B1ALDH1A1POLBRXFP1KDM4E
SCHEMBL29180980 0.71 CYP1B1 (0.52) CYP1B1ALDH1A1POLBRXFP1KDM4E
SCHEMBL24316240 0.67 CYP1B1 (0.41) CYP1B1ALDH1A1POLBRXFP1KDM4E
SCHEMBL22549649 0.65 ALDH1A1 (0.35) ALDH1A1KDM4ESMN1; SMN2KMT2ALMNA
SCHEMBL30517121 0.65 PKM (0.57) CYP1B1ALDH1A1POLBKDM4EKMT2A
SCHEMBL12561180 0.65 PKM (0.57) CYP1B1ALDH1A1POLBKDM4EKMT2A
SCHEMBL10413423 0.64 CYP1B1 (0.78) CYP1B1ALDH1A1POLBRXFP1KDM4E
SCHEMBL30837348 0.64 CYP1B1 (0.78) CYP1B1ALDH1A1POLBRXFP1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022081927-A1 TRICYCLIC COMPOUNDS TO DEGRADE NEOSUBSTRATES FOR MEDICAL THERAPY C4 THERAPEUTICS, INC. (US) 2022-04-21 WO disclosed